PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2026TheranosticsOpen Access

From nanotags to precision biomedicine: SERS-driven progress and innovation in tumor biomarker profiling, dynamic bioimaging, AI-enhanced diagnostics and therapy

View Full Paper
Ask AI
Bookmark
Share

Authors

XCXuelin ChenTLTenglong LiuWCWeiyuan Chen

Discussion

Loading...

Member takes

Overview

Randomized trial explores SERS technology for tumor biomarker profiling and AI-enhanced diagnostics, suggesting advancements in precision biomedicine.

Key Points

  • This research aims to investigate the advancements of SERS technology in tumor diagnostics and treatment.
  • Evaluated AI-assisted spectral analysis for tumor diagnostics.
  • Reviewed multimodal integration and standardized detection protocols.
  • Discussed large-scale clinical applications of SERS technology.
  • SERS technology enhances tumor biomarker profiling.
  • AI-assisted diagnostics show improved precision in bioimaging.
  • Integration of SERS in clinical settings suggests potential for point-of-care applications.

Cite This Study

Chen et al. (2026) studied this question.

synapsesocial.com/papers/6a64f169f883a62dea1c4332https://doi.org/10.7150/thno.126530
View Full Paper
Ask AI
Bookmark
Share